Search Results - "Glad, Camilla A M"

Refine Results
  1. 1

    A polymorphism in the CYP17A1 gene influences the therapeutic response to steroidogenesis inhibitors in Cushing's syndrome by Valassi, Elena, Aulinas, Anna, Glad, Camilla AM, Johannsson, Gudmundur, Ragnarsson, Oskar, Webb, Susan M

    Published in Clinical endocrinology (Oxford) (01-11-2017)
    “…Summary Context Steroidogenesis inhibitors, such as ketoconazole (KTZ) and metyrapone (MTP), are used to lower hypercortisolism in patients with Cushing's…”
    Get full text
    Journal Article
  2. 2
  3. 3

    The GH/IGF-1 axis in obesity: pathophysiology and therapeutic considerations by Berryman, Darlene E., Glad, Camilla A. M., List, Edward O., Johannsson, Gudmundur

    Published in Nature reviews. Endocrinology (01-06-2013)
    “…Administration of recombinant human growth hormone (GH) or activation of endogenous GH production exhibits great potential to influence the onset and metabolic…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Reverse Feeding Suppresses the Activity of the GH Axis in Rats and Induces a Preobesogenic State by Glad, Camilla A.-M, Kitchen, Edward E. J, Russ, Gemma C, Harris, Sophie M, Davies, Jeffrey S, Gevers, Evelien F, Gabrielsson, Britt G, Wells, Timothy

    Published in Endocrinology (Philadelphia) (01-03-2011)
    “…Daytime-only feeding in rats suppresses the GH axis, desynchronizes central and peripheral clock mechanisms, and increases the efficiency of lipid storage in…”
    Get full text
    Journal Article
  6. 6

    Genome-wide DNA Methylation Differences in Nonfunctioning Pituitary Adenomas With and Without Postsurgical Progression by Hallen, Tobias, Johannsson, Gudmundur, Dahlen, Rahil, Glad, Camilla A. M, Skoglund, Thomas, Olsson, Daniel S

    “…Abstract Context Tumor progression in surgically treated patients with nonfunctioning pituitary adenomas (NFPAs) is associated with excess mortality. Reliable…”
    Get full text
    Journal Article
  7. 7

    Expression of GHR and Downstream Signaling Genes in Human Adipose Tissue—Relation to Obesity and Weight Change by Glad, Camilla A M, Svensson, Per-Arne, Nystrom, Fredrik H, Jacobson, Peter, Carlsson, Lena M S, Johannsson, Gudmundur, Andersson-Assarsson, Johanna C

    “…Abstract Context GH is a strong regulator of metabolism. In obesity, both GH secretion and adipose tissue GHR gene expression are decreased. More detailed…”
    Get full text
    Journal Article
  8. 8
  9. 9

    SNPs within the GH-signaling pathway are associated with the early IGF1 response to GH replacement therapy in GHD adults by Glad, Camilla A M, Barbosa, Edna J L, Filipsson Nyström, Helena, Carlsson, Lena M S, Nilsson, Staffan, Nilsson, Anna G, Svensson, Per-Arne, Johannsson, Gudmundur

    Published in European journal of endocrinology (01-01-2014)
    “…ObjectiveGH-deficient (GHD) adults have reduced serum concentrations of IGF1. GH replacement therapy increases serum IGF1 concentrations, but the…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Cell death–inducing DFF45-like effector C is reduced by caloric restriction and regulates adipocyte lipid metabolism by Magnusson, Björn, Gummesson, Anders, Glad, Camilla A.M, Goedecke, Julia H, Jernås, Margareta, Lystig, Theodore C, Carlsson, Björn, Fagerberg, Björn, Carlsson, Lena M.S, Svensson, Per-Arne

    Published in Metabolism, clinical and experimental (01-09-2008)
    “…Abstract Members of the cell death–inducing DFF45-like effector (CIDE) gene family have been shown to regulate lipid metabolism. In this article, we report…”
    Get full text
    Journal Article
  13. 13

    Visceral Fat and Novel Biomarkers of Cardiovascular Disease in Patients With Addison’s Disease: A Case-Control Study by Bergthorsdottir, Ragnhildur, Ragnarsson, Oskar, Skrtic, Stanko, Glad, Camilla A M, Nilsson, Staffan, Ross, Ian Louis, Leonsson-Zachrisson, Maria, Johannsson, Gudmundur

    “…Abstract Context Patients with Addison’s disease (AD) have increased cardiovascular mortality. Objective To study visceral fat and conventional and exploratory…”
    Get full text
    Journal Article
  14. 14

    Reduced DNA methylation and psychopathology following endogenous hypercortisolism – a genome-wide study by Glad, Camilla A. M., Andersson-Assarsson, Johanna C., Berglund, Peter, Bergthorsdottir, Ragnhildur, Ragnarsson, Oskar, Johannsson, Gudmundur

    Published in Scientific reports (16-03-2017)
    “…Patients with Cushing’s Syndrome (CS) in remission were used as a model to test the hypothesis that long-standing excessive cortisol exposure induces changes…”
    Get full text
    Journal Article
  15. 15
  16. 16

    MECHANISMS IN ENDOCRINOLOGY: Clinical and pharmacogenetic aspects of the growth hormone receptor polymorphism by Boguszewski, Cesar L, Barbosa, Edna J L, Svensson, Per-Arne, Johannsson, Gudmundur, Glad, Camilla A M

    Published in European journal of endocrinology (01-12-2017)
    “…Pharmacogenetics aims to maximize the beneficial effects of a medical therapy by identifying genetic finger prints from responders and non-responders and,…”
    Get full text
    Journal Article
  17. 17
  18. 18

    The GH receptor exon 3 deleted/full-length polymorphism is associated with central adiposity in the general population by Glad, Camilla A M, Carlsson, Lena M S, Melander, Olle, Almgren, Peter, Sjöström, Lars, Nilsson, Staffan, Larsson, Ingrid, Svensson, Per-Arne, Johannsson, Gudmundur

    Published in European journal of endocrinology (01-02-2015)
    “…ObjectiveTo test the hypothesis that the GH receptor (GHR) exon 3 deleted (d3)/full-length (fl) polymorphism influences anthropometry and body composition in…”
    Get full text
    Journal Article
  19. 19

    Pseudoacromegaly: A Differential Diagnostic Problem for Acromegaly With a Genetic Solution by Dahlqvist, Per, Spencer, Rupert, Marques, Pedro, Dang, Mary N, Glad, Camilla A M, Johannsson, Gudmundur, Korbonits, Márta

    Published in Journal of the Endocrine Society (01-08-2017)
    “…Acromegaly is usually not a difficult condition to diagnose once the possibility of this disease has been raised. However, a few conditions present with some…”
    Get full text
    Journal Article
  20. 20

    Rapid and high throughput genotyping of the growth hormone receptor exon 3 deleted/full-length polymorphism using a tagSNP by Glad, Camilla A.M, Johannsson, Gudmundur, Carlsson, Lena M.S, Svensson, Per-Arne

    Published in Growth hormone & IGF research (01-06-2010)
    “…Abstract Objective The growth hormone (GH) receptor (GHR) exon 3 deleted/full-length (d3/fl) polymorphism has been suggested to affect GH sensitivity. The…”
    Get full text
    Journal Article